PRESS RELEASE published on 05/31/2023 at 18:30, 2 years 6 months ago Voyager Metals and Cerrado Gold Announce Completion of Business Combination Transaction
PRESS RELEASE published on 05/29/2023 at 17:30, 2 years 6 months ago Voyager Metals Announces Filing of Initial Project Description for the Mont Sorcier Project to Commence Federal Permitting Process
PRESS RELEASE published on 05/25/2023 at 12:00, 2 years 6 months ago Voyager Metals Securityholders Approve Arrangement with Cerrado Gold
PRESS RELEASE published on 05/04/2023 at 12:00, 2 years 7 months ago Voyager Metals Inc. Notifies Securityholders of Upcoming Special Meeting
PRESS RELEASE published on 03/16/2023 at 22:00, 2 years 8 months ago Early Warning Report Regarding Voyager Metals Inc.
PRESS RELEASE published on 03/15/2023 at 22:00, 2 years 8 months ago Voyager Metals Closes Previously Announced Private Placement for $4.725 Million
PRESS RELEASE published on 03/08/2023 at 03:00, 2 years 8 months ago Voyager Metals Announces Business Combination with Cerrado Gold
Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
